PATENT CLAIM ANALYSIS

Application Number: 16322264
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-06
Patent Classification: ["514", "235800"]

Abstract:
Pyrimidine derivatives of formula (I) wherein: Z is a direct bond or —(CH 2 ) n — wherein n is 1 or 2; one of X and Y is N, CH or CF, and the other of X and Y is CH; one of R 1  and R 2  is selected from —NHR, —NR 2 , —OR, —SR, —S(O)R, —S(O) 2 R and a group of the following formula (A) and the other of R 1  and R 2  is selected from —NHR′, —OH, —OR′ and a group of the above formula (A); R is unsubstituted C 1 -C 6  alkyl; R′ is a group selected from C 1 -C 6  alkyl, 5- to 12-membered aryl and C 3 -C 6  cycloalkyl, which group is unsubstituted or substituted; W is —(CH 2 ) m —, —CH 2 —O—CH 2 —, —CH 2 —S—CH 2 — or —CH 2 —S(O) 2 —CH 2 —; p is 1, q is an integer of 1-6 and V is N; or p is 1, q is 0 and V is CH; or p is 0, q is 0 and V is N; r is 0 or 1; and R 3  is —(CH 2 ) s —NH 2  or —(CH 2 ) s —OH wherein s is 0 or an integer of 1 to 4; and the pharmaceutically acceptable salts thereof are inhibitors of RSV and can therefore be used to treat or prevent an RSV infection.

Claim (Index 3):
A compound according to  claim 1  wherein Z is a direct bond.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 3.23077
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15517290', '14357293', '14435604', '15023465', '14971120']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8135303925181911
- 35 USC 102 Novelty (BERT): 0.5406449504818445
- Combined Prediction Score: 0.7862418483145565
- Mean Citation Score: 328.202194
- Max Citation Score: 397.06805
- Similarity Product: 237.9375219123185

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test